Pharmacotherapy and Intensive Treatment of Drug Abuse - 1

Phase 2

Completed

• Conditions: Substance-Related Disorders; Cocaine-Related Disorders

• Registration Number: NCT00000217
• Lead Sponsor: University of Kansas

Brief Summary

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

Detailed Description

Not available

Study Timeline

• Study Start: 1990-09
• Primary Completion: 1996-10
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2015-04
• Last Update Submitted: 2015-04-15
• Last Update Posted: 2015-04-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Retention
Depression, anxiety
Drug use
Level of pharm
Effectiveness of medication

Trial Locations

Locations (1)

University of Kansas; 🇺🇸 Kansas City, Missouri, United States